Artificial human white blood cell 'Mylc'
You can choose from three types of genetic backgrounds according to your purpose! The flexibility of evaluation expands.
"Mylc" is a human dendritic cell produced using iPS cell technology (regenerative medicine technology), controlled in an ideal "immature (pre-stimulation)" state for research and evaluation. It can reproduce the same genetic information and state multiple times, significantly improving the accuracy and applicability of pharmaceutical evaluations. Additionally, it allows for the acquisition of blood cells in the ideal state in any required quantity, enabling smooth execution of research and development as well as efficacy evaluations, thus accelerating the development process. 【Features】 - Homogeneous blood cells with identical genetic information - Free control over appropriate differentiation stages - Large-scale and stable production and supply possible *For more details, please download the PDF or feel free to contact us.
- Company：マイキャン・テクノロジーズ
- Price：Other
